Portfolio News

We are excited to announce that Perfectus Biomed are now a GLP Compliant laboratory. Following an Inspection for Compliance in October this year, we successfully demonstrated compliance with OECD Principles of Good Laboratory Practice and were accepted into the UK GLP Compliance Monitoring Programme.   What is GLP? Good Laboratory Practice (GLP) is a quality control […]

read more

New Chairman Brings “Wealth of Experience” to Pioneering Biotech Firm Simon Sturge, Executive Vice President of Business, Operations and Strategy at Merck Healthcare, is today confirmed as the new Chairman of Nemesis Bioscience, the British biotechnology business tackling antibiotic resistance with breakthrough technologies. This is a very significant appointment for Nemesis given Mr Sturge’s extensive career in senior roles across the pharmaceutical and biotech sectors. He founded RiboTargets;… The post LEADING PHARMACEUTICAL EXECUTIVE JOINS NEMESIS BIOSCIENCE appeared first on Nemesis Bioscience.

read more

Tokamak Energy is pleased to announce that it has closed its latest investment round, taking the total amount of investment in the business to over £50 million. Tokamak Energy is aiming to accelerate the commercialisation of fusion energy through the development of compact modular power plants, which can be rapidly deployed at scale. Fusion produces […]

read more

The global “Explosives Detector Market” market gives a huge platform for different firms, manufacturers, and organizations, such as, CEIA, Cobalt Light ...

read more

Takeda has the right to develop and commercialise Humabody-based therapeutics on the basis of its collaboration with Crescendo Biologics agreed ...

read more

1 3 4 5